Crest Nicholson - CRST Share Forecast, Price & News

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Crest Nicholson in the last twelve months. There are currently 1 sell rating, 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" CRST shares.
View CRST analyst ratings or view top-rated stocks.

6 Wall Street research analysts have issued 12 month target prices for Crest Nicholson's stock. Their CRST share price forecasts range from GBX 220 to GBX 460. On average, they anticipate the company's stock price to reach GBX 337.50 in the next twelve months. This suggests a possible upside of 44.7% from the stock's current price.
View analysts price targets for CRST or view top-rated stocks among Wall Street analysts.

Crest Nicholson's stock was trading at GBX 372 on January 1st, 2022. Since then, CRST stock has decreased by 37.3% and is now trading at GBX 233.20.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, January 17th 2023.
View our CRST earnings forecast.

Crest Nicholson Holdings plc (LON:CRST) released its quarterly earnings results on Tuesday, June, 12th. The company reported $23.80 earnings per share for the quarter.

Crest Nicholson declared a dividend on Tuesday, June 14th. Stockholders of record on Thursday, September 22nd will be paid a dividend of GBX 5.50 per share on Thursday, October 13th. This represents a dividend yield of 2.16%. The ex-dividend date is Thursday, September 22nd. The official announcement can be viewed at this link.
Read our dividend analysis for CRST.

Crest Nicholson (LON:CRST) pays an annual dividend of GBX 0.14 per share and currently has a dividend yield of 6.65%. CRST has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
Read our dividend analysis for CRST.

Based on aggregate information from My MarketBeat watchlists, some companies that other Crest Nicholson investors own include Bristol-Myers Squibb (BMY), Interserve (IRV), Petra Diamonds (PDL), Arconic (ARNC), Berry Global Group (BERY), Micron Technology (MU), Plexus (PLXS), Rexnord (RXN) and Taylor Wimpey (TW).

Crest Nicholson trades on the London Stock Exchange (LON) under the ticker symbol "CRST."

Shares of CRST stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

One share of CRST stock can currently be purchased for approximately GBX 233.20.

Crest Nicholson (LON:CRST) has a market capitalization of £599.14 million and generates £826.40 million in revenue each year.

The company employs 700 workers across the globe.

Crest Nicholson's mailing address is Crest House, Pyrcroft Road, CHERTSEY, KT16 9GN, United Kingdom. The official website for the company is www.crestnicholson.com. The company can be reached via phone at +44-1932-580555.